Company / Gross Profit per Share
Fulgent Genetics, Inc. Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$4.24
FY2025
5-year range
$0.65 / $26.40
FY2021-FY2025
Trend
+17.4%
vs FY2024
Sector context
#73 of 99
Health Care
What the data says
At $4.24, Fulgent Genetics, Inc.'s gross profit per share ranks #73 of 99 in the Health Care sector. Gross Profit per Share has fluctuated over the past 10 years, ranging from $0.02 in FY2016 to $26.40 in FY2023.
Based on SEC 10-K filings.
4.24 in FY2025 with a 5-year CAGR of -22.8%.
Declined from $26.40 to $4.24 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -27.2%
- 5-Year CAGR
- -22.8%
- 10-Year CAGR
- -
Sector benchmark
#73 of 99 in Health CareTop 74% of 99This company $4.24 Sector average $13.98
▼
-69.6% below sector average
Key checks
Key Insights
- In FY2025, gross profit per share increased 17.4% year-over-year.
- Ranks #73 out of 99 companies in the Health Care sector.
- Peak gross profit per share was recorded in FY2023.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.24 | +17.4% |
| FY2024 | $3.62 | -86.3% |
| FY2023 | $26.40 | +139.9% |
| FY2022 | $11.00 | +1583.4% |
| FY2021 | $0.65 | -95.8% |
| FY2020 | $15.45 | +2535.2% |
| FY2019 | $0.59 | +2.8% |
| FY2018 | $0.57 | -1.0% |
| FY2017 | $0.58 | +2876.3% |
| FY2016 | $0.02 | -94.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026